TP53 and head and neck squamous cell carcinoma: The HSP70 inhibitor VER-155008 decreases the ThT signal in the Detroit 562 cell line, a head and neck squamous cell carcinoma (HNSCC) cell line harboring the p53 R175H mutation [11].